Analyst Rating: Will Companhia Brasileira de Distribuicao (CBD) Stock Beat the Market?

Wednesday, May 04, 2022 10:24 AM | InvestorsObserver Analysts

Mentioned in this article

Analyst Rating: Will Companhia Brasileira de Distribuicao (CBD) Stock Beat the Market?

InvestorsObserver is giving Companhia Brasileira de Distribuicao (CBD) an Analyst Rating Rank of 16, meaning CBD is ranked higher by analysts than 16% of stocks. The average price target for CBD is $5.75 and analyst’s rate the stock as a Buy.

Wall Street analysts are rating CBD a Buy today. Find out what this means to you and get the rest of the rankings on CBD!

See Full CBD Report

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With Companhia Brasileira de Distribuicao Stock Today?

Companhia Brasileira de Distribuicao (CBD) stock is higher by 2.2% while the S&P 500 is lower by -0.38% as of 10:23 AM on Wednesday, May 4. CBD has risen $0.09 from the previous closing price of $4.32 on volume of 318,579 shares. Over the past year the S&P 500 has fallen -0.12% while CBD is lower by -37.39%. CBD earned $0.60 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 7.32. Click Here to get the full Stock Report for Companhia Brasileira de Distribuicao stock.